Tumor-related IGF2BP1-derived molecular subtypes to predict prognosis and immune microenvironment in head and neck squamous cell carcinoma
This study highlights the crucial link between RNA modification and TME diversity. Evaluating RNA modification in tumors improves our understanding of TME features and supports the development of effective immunotherapy strategies.
Authors
- Sufang Qiu (ORCID: https://orcid.org/0000-0001-7660-6955)
- Dan Hu (ORCID: https://orcid.org/0000-0002-0994-8434)
- Qin Ding
- Ziyi Wu (ORCID: https://orcid.org/0000-0001-6207-381X)
- Jing Wang (ORCID: https://orcid.org/0000-0002-5398-0802)
- Yi Li (ORCID: https://orcid.org/0000-0003-0398-0967)
- Mingzhu Liu
- Xiaoyong Liu (ORCID: https://orcid.org/0000-0002-8808-010X)
- Yuhui Pan
- Jinghua Lai (ORCID: https://orcid.org/0009-0005-4528-7564)
Institutions
- Fujian Medical University (CN)
- Fudan University Shanghai Cancer Center (CN)
- Fujian Provincial Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-10-24
- DOI
- https://doi.org/10.3389/fimmu.2024.1469435
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- Fujian Provincial Health Commission
- Wu Jieping Medical Foundation